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Nutritional status during development can modify the brain’s electrophysiological properties and its
response to drugs that reduce the serotonin availability in the synaptic cleft. Here we used cortical
spreading depression (CSD) in the rat as a neurophysiological parameter to investigate the interaction
between nutritional status and treatment with tianeptine, a serotonin uptake enhancer. From postnatal
day 2 to 24, well-nourished and early-malnourished rat pups were s.c. injected with tianeptine (5 or
10 mg/kg; 10 ml/kg) or equivalent volume of saline solution (control group). When the animals were
25–30 days old, CSD was recorded on the brain cortical surface. In the well-nourished rats, but not in
the malnourished group, systemic tianeptine dose-dependently increased the CSD propagation velocity,
with 10 mg/kg producing a signiﬁcant (Po0.05) effect. An experiment in adult rats showed that
cortical topical application of tianeptine solutions (5 mg/ml, 10 mg/ml, and 20 mg/ml) increased the
CSD propagation in both the well-nourished and early-malnourished conditions. In well-nourished
animals, 0.5 mg/ml topical tianeptine did not affect CSD propagation, and 2 mg/ml produced a small,
but signiﬁcant CSD acceleration. Our results indicate a facilitating action of tianeptine on CSD
propagation, probably via tianeptine’s pharmacological action on the serotonin system. These ﬁndings
support previous data suggesting an antagonistic role of the serotoninergic system on CSD.
& 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Nutritional status during development is an exogenous factor
that can inﬂuence the mammalian brain (Borba et al., 2000;
Morgane et al., 1993; Picanc-o-Diniz et al., 1998). It has been
reported that nutritional status can modulate levels of several
neurotransmitters in the brain, either in early stages of life or in
adulthood, and there is some evidence that malnutrition can
interfere with serotonin activities in the brain (Manh~aes-de-
Castro et al., 2001; Manjarrez et al., 1998).
Serotoninergic neurons are among the ﬁrst to develop in the
mammalian brain, and can act as a trophic factor for the devel-
opment of other neurons (Azmitia and Whitaker-Azmitia, 1995;
Lauder et al., 1981). Serotonin reportedly has an antagonistic
action on epileptic seizures and migraine, two neurologicalax: þ55 81 2126 8473.
aiabr@yahoo.com.br,
e.br,
ier OA license.disorders associated with changes in brain excitability (Gold
et al., 1998; Lu and Gean, 1998; Salgado-Commissariat and
Alkadhi, 1997). Moreover, the serotoninergic system has been
shown to counteract cortical spreading depression (CSD), a brain
electrophysiological phenomenon that is also related to neuronal
excitability (Amaˆncio-dos-Santos et al., 2006; Guedes et al., 2002).
This relationship is analyzed in the present work.
CSD is a self-propagating wave of depolarization associated
with depression of spontaneous and evoked neuronal bioelectri-
cal activity, which lasts for several minutes before completely
recovering (Gorji, 2001). CSD can be induced with different
stimuli (Bure´s et al., 1974; Le~ao, 1944; Le~ao and Morrison,
1945) and it has been postulated that its mechanisms are related
to those of the relevant human neurological diseases epilepsy,
migraine, and brain ischemia (Le~ao, 1944; Lehmenku¨hler et al.,
1993; Takano et al., 1996). Under normal conditions, the cortical
tissue presents a certain degree of resistance to CSD propagation;
experimental manipulations can increase or decrease such resis-
tance, resulting in, respectively, lower or higher CSD velocities of
propagation (Guedes and Do-Carmo, 1980; Rocha-de-Melo et al.,
2006). Therefore, the susceptibility of the brain to CSD can be
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the cerebral cortex. Studying the pharmacological experimental
conditions that facilitate or impair the brain’s ability to produce
and propagate CSD can advance our understanding of electro-
physiological brain phenomena and related diseases (Costa-Cruz
et al., 2006; Guedes and Cavalheiro, 1997). It has been established
that serotonin-enhancing drugs decrease CSD propagation, sug-
gesting an antagonistic action of serotonin on CSD (Cabral-Filho
et al., 1995; Guedes et al., 2002; Amaˆncio-dos-Santos et al., 2006).
However, no information is available regarding the CSD effects of
drugs like tianeptine that diminish brain serotonin availability.
The present study of young and adult rat brains subjected to
systemic and topical tianeptine application addresses three questions:
(1) how does systemic administration of tianeptine during brain
development subsequently affect CSD propagation? (2) after brain
development, does topical application of tianeptine in the adult rat
affect CSD? and (3) how are the systemic and topical effects of
tianeptine on CSD inﬂuenced by the previous nutritional condition?Fig. 1. Body weights of young and adult rats that were well nourished and
malnourished during the lactation period. Data are presented as mean7S.E.M.
Asterisks in the malnourished groups indicate signiﬁcant weight reduction
compared with the respective well-nourished groups. (ANOVA plus Tukey-test;
Po0.05). Young well-nourished, n¼7; Adult well-nourished, n¼9; Young mal-
nourished, n¼8; Adult malnourished, n¼10.2. Materials and methods
2.1. Animals and suckling conditions
Newborn Wistar rats (n¼104) were raised under one of the
following two nutritional conditions during the suckling period:
(a) well-nourished (n¼57), i.e., suckled by dams fed a standard
lab chow diet (Purina do Brasil Ltd., Paulinia, S~ao Paulo, Brazil)
with 23% protein; or (b) early-malnourished (n¼47), i.e., suckled
by dams fed a deﬁcient diet containing 8% protein. The animals
were handled in accordance with the standards of the Ethics
Committee for Animal Research, of the Universidade Federal de
Pernambuco, Brazil, which comply with the ‘‘Principles of Labora-
tory Animal Care’’ (NIH; Bethesda, USA).
2.2. Systemic tianeptine treatment
Well-nourished and malnourished animals were treated subcuta-
neously with 5 or 10mg/kg/day tianeptine (n¼9 and 7, respectively,
for the well-nourished condition, and n¼10 and 9 for the malnour-
ished condition) or an equivalent volume (10ml/kg) of saline (n¼7
and 8, respectively, for the well-nourished and malnourished condi-
tions). Injections were given at 7 a.m. daily throughout the suckling
period (postnatal days 2–24). Each rat pup was weighed daily during
the suckling period and on the day of the CSD recording (between
postnatal day 25 and 30).
2.3. Cortical topical tianeptine treatment
Tianeptine solutions containing 5, 10, or 20 mg/ml were topically
applied in three groups each of well-nourished and malnourished
adult rats (90–150 days old; n¼9, 8, and 7 for the well-nourished
condition, and n¼6, 8, and 6 for the malnourished condition). This
topical application was performed on two circular portions (3- to 4-
mm diameter) of the cortical surface (over the intact dura-mater)
where the recording electrodes were placed. After 1–2 h of baseline
CSD recording, tianeptine was applied during the last 10 min of the
20-min interval between two consecutive CSD-eliciting KCl-stimu-
lations (see below). At the end of the 10-min topical application, the
treated region was dried with a piece of cotton immediately before
the next CSD episode was elicited. After the tianeptine-effect
had been documented, at least three subsequent CSD episodes were
stimulated without any drug application in order to document
the recovery of CSD-features. CSD propagation velocities recorded
after topical application of tianeptine were compared to mean
values obtained in the same animals during the baseline period.In the well-nourished condition, topical application of 0.5 mg/ml
and 2 mg/ml of tianeptine were also tested (n¼5 for each
concentration).2.4. CSD recording
On the day of the CSD recording, the rats were anesthetized i.p.
with a mixture of 1000mg/kg urethane plus 40mg/kg chloralose, and
three trephine holes were drilled on the right side of the skull. These
holes were aligned in the frontal–occipital direction and were parallel
to the midline. CSD was elicited at 20 min intervals by 1-min topical
application of 2% KCl solution to the anterior hole (2 mm in diameter)
drilled at the frontal region. The two other holes (3–4mm in
diameter) on the parieto-occipital region served as recording places.
Both the cortical spontaneous electrical activity (electrocorticogram;
ECoG) and the slow potential change accompanying CSD were
continuously recorded for 4 h, using two Ag–AgCl agar-Ringer elec-
trodes (one in each hole) against a common reference electrode of the
same type placed on the nasal bones (see inset of Figs. 2 and 4). The
CSD velocity of propagation was calculated from the time required for
a CSD wave to pass the distance between the two cortical recording
points. During the recording period, rectal temperature was main-
tained at 3771 1C by means of a heating blanket. At the end of the
session, the animal was killed with an overdose of anesthetic.2.5. Statistics
Body weights, as well as CSD velocities, were compared using
ANOVA followed by post-hoc (Tukey-Kramer) test, when indi-
cated. The paired t-test was employed to analyze the effects of
topical tianeptine application by comparing, in the same animal,
CSD-features before and after the treatment. Differences were
considered signiﬁcant when Po0.05.3. Results
3.1. Body weights
As shown in Fig. 1, early-malnourished rats displayed lower
body weights than the well-nourished animals, both at 25–35
days and 90–120 days of life. In the young group, body weights of
the rats treated systemically with tianeptine did not differ from
those of saline-treated rats with the same nutritional status (data
not shown).
Fig. 2. Electrocorticogram (E) and slow potential change (P) recordings in well-nourished and malnourished young rats (25–30 days old) that were treated during the
lactation period with s.c. injections of tianeptine (5 mg/kg or 10 mg/kg) or saline solution (10 ml/kg). The center inset shows recording positions 1 and 2, as well as the
position of the common reference electrode (R). CSD was elicited by 2% KCl applied for 1 min to the frontal cortex at the time indicated by the horizontal bars (P1-traces).
The vertical bars correspond to 10 mV in P and 0.5 mV in E (negative upward).
Fig. 3. CSD velocities in well-nourished and malnourished young rats (25–30 days
old) that were treated during the lactation period with s.c. injections of tianeptine
(5 mg/kg or 10 mg/kg) or with a corresponding volume of saline solution
(10 ml/kg). Values are expressed as mean7S.E.M. # denotes that the CSD velocity
in the well-nourished tianeptine-10 group is signiﬁcantly higher (Po0.05) than in
the respective saline group. Asterisks indicate malnourished groups with higher
CSD-velocities compared with the corresponding well-nourished groups (Po0.05;
ANOVA plus Tukey test). The saline group is represented by the white bar.
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3.2.1. Systemic tianeptine treatment
Fig. 2 illustrates ECoG and DC-recordings in the parietal cortex
of three well-nourished and three malnourished rats that were
treated systemically with saline or tianeptine at doses of 5 or
10 mg/kg. Stimulation with KCl for 1 min consistently elicited
CSD, which propagated and was recorded by the two electrodes at
the parietal surface of the same hemisphere (see stimulation and
recording places at the inset of Fig. 2). After a few min of
recording CSD, we observed the gradual return of the ECoG and
the slow potential changes back to the pre-CSD levels.
As a rule, we recorded 10 to 12 CSD episodes (elicited at 20 min
intervals), and we calculated the mean CSD velocity of propagation
for each animal. Fig. 3 shows these mean values for the saline,
tianeptine-5, and tianeptine-10 groups. In the well-nourished
animals, early systemic tianeptine treatment resulted in higher
CSD velocities compared to those of the corresponding saline-
treated groups; the CSD velocity increase was statistically signiﬁ-
cant when the highest dose was administered (group tianeptine-
10; left panel of Fig. 3), suggesting that the systemic effect of
tianeptine on CSD was dose-dependent (Fig. 3, left panel). The
mean velocities (7standard deviation) for the well-nourished
groups treated with saline, and 5 and 10 mg/kg tianeptine were,
respectively, 3.8670.25, 3.9670.11, and 4.6170.34 mm/min.
When compared to the well-nourished animals, malnourished
rats presented higher CSD velocities. In the malnourished rats,
systemic tianeptine treatment did not result in signiﬁcant CSDenhancement compared to in the saline group (right panel of
Fig. 3). The mean velocities (7standard deviation) for the mal-
nourished groups treated systemically with saline, and 5 and
10 mg/kg tianeptine were, respectively, 4.3870.16, 4.6170.27,
and 4.5370.13 mm/min.3.2.2. Topical cortical treatment with tianeptine
Fig. 4 illustrates the effect of topical treatment with 10 mg/ml
tianeptine solution on CSD propagation. In both well-nourished
Fig. 4. Slow potential change (P) recordings in well-nourished and early-mal-
nourished adult rats (90–150 days old) showing the effects of topical applications
of tianeptine solution (10 mg/ml) on CSD. The upper-central inset shows recording
positions 1 and 2, as well as the position of the common reference electrode (R).
CSD was elicited by 2% KCl applied for 1 min to the frontal cortex at the time
indicated by the horizontal bars (P1-traces). The vertical bars correspond to 10 mV
(negative upward). In every animal, Control: a baseline CSD recording, i.e., before
tianeptine topical treatment; Tianeptine: represents the topical drug treatment
period. The tianeptine recordings show a decrease in the latency of a CSD wave
crossing the distance between the two recording points. 400 post-Tianeptine: the
recovery from the topical drug effect, which was reached 40 min after tianeptine
removal.
Fig. 5. Enhancements of CSD-velocity in adult rats who were well nourished and
malnourished in the lactation period, after topical cortical application of tianep-
tine solutions during the 10 min immediately preceding CSD elicitation with KCl.
Tianeptine was topically applied to a circular area (3- to 4-mm diameter) of the
parietal cortical surface (recording place) on the intact dura-mater. Tianeptine
solutions with the following concentrations (mg/ml) were used: in the well-
nourished rats, 0.5, 2, 5, 10 and 20; in the malnourished rats, 5, 10 and 20. Data are
expressed as mean7S.E.M. Control: baseline CSD velocities, i.e., before tianeptine
topical treatment. Tianeptine: maximal increase of CSD velocities obtained after
tianeptine topical application. Recovery: CSD velocities after tianeptine cortical
removal. The symbol # indicates that all malnourished values are signiﬁcantly
different from the corresponding well-nourished values (Po0.05; ANOVA plus
Tukey test). nPo0.05 compared with the corresponding control period. $Po0.05
compared with the other tianeptine concentrations. &Po0.05 compared with the
groups treated with 0.5 mg/ml and 2 mg/ml tianeptine solutions.
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for 10 min over the intact dura mater at both trephine holes used
for the electrophysiological recordings. This application decreased
the latency (i.e., enhanced the velocity) of a CSD wave crossing
the distance between the two recording points. After tianeptine
removal, the CSD propagation velocity returned to the pretreat-
ment levels (see the time between the dashed lines in Fig. 4).
Fig. 5 presents the increase of CSD velocities in well-nourished
and malnourished rats after topical application of the tianeptine
solutions. In the well-nourished animals, treatment with 0.5 mg/ml
tianeptine did not change the CSD velocity, as compared to the
control values. Application of the more concentrated solutions (2, 5,
10, and 20 mg/ml tianeptine) produced signiﬁcant, dose-dependent
increases in CSD propagation velocity. The maximal percent
increases of CSD velocity (mean7standard deviation) were
11.872.7%, 18.875.8%, 19.977.7%, and 20.578.6%, respectively.
In the malnourished groups these signiﬁcant percent increases were,
respectively, 19.7711.1%, 16.076.9%, and 30.1711.9%. The max-
imal CSD velocity increases were attained between 10–110 min
after tianeptine application, and the recovery of these tianeptine
effects took 20–80 min after the maximal increase.4. Discussion
Here we demonstrated for the ﬁrst time that systemic admin-
istration of the serotonin reuptake enhancer tianeptine during
brain development had an accelerating effect on CSD propagation.Since the serotoninergic system starts to develop early in life
(Azmitia and Whitaker-Azmitia, 1995; Lauder et al., 1981; Yew
and Chan, 1999), we administered systemic tianeptine treatment
to rats during the suckling period, and thus could analyze
serotoninergic inﬂuences during the brain growth spurt and their
relationships with nutritional status.
Early tianeptine administration did not affect body weight, as
there were no differences in body weight between treated
animals and their respective controls injected with saline solu-
tion. Previous studies have shown a role for serotonin in promot-
ing satiety (Blundell, 1992; Garattini, 1995; Silverstone, 1992;
Simansky, 1996). Indeed, stimulation of the serotoninergic system
has been related with body weight reduction, and serotoninergic
drugs are currently used as adjuvant treatment to help reduce
food ingestion (Redman and Ravussin, 2010). The main pharma-
cological mechanism of action of tianeptine is based on its
capacity to reduce serotonin levels in several brain areas (Lechin
et al., 2006; Mennini et al., 1987); accordingly, an increase in body
weight could be expected following treatment. However, in
contrast, hypophagia has been observed in rats after tianeptine
treatment (Chaouloff, 1993). Concerning nutritional status, our
early-malnourished animals presented lower body weights com-
pared to the well-nourished ones, and this weight difference
persisted until adulthood when malnourishment was no longer
present. This ﬁnding conﬁrms previous data indicating that
nutritional insult during development can have lasting effects
on the body and/or brain (Rocha-de-Melo et al., 2006).
The main electrophysiological ﬁnding of this work was a
tianeptine-induced increase in CSD propagation velocity. As men-
tioned above, this drug can reduce serotonin availability in the brain
cortex (Mennini et al., 1987), which was the region in which we
recorded CSD. We believe that the facilitating effect of tianeptine
on CSD propagation probably depends on the pharmacological action
of this drug on the serotonin system. The literature shows that CSD
is antagonized by several drugs that enhance serotoninergic activity,
such as citalopram (Guedes et al., 2002), ﬂuoxetine (Amaˆncio-
dos-Santos et al., 2006), d-fenﬂuramine (Cabral-Filho et al., 1995),
and Sumatriptan (Read and Parsons, 2000). Furthermore, acute
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impairs CSD propagation (Trindade-Filho et al., 2009). These effects
were attributed to the increase in brain cortical serotonin activity
caused by such drugs. The present results reinforce previous data
concerning a putative antagonistic inﬂuence of the serotoninergic
system on CSD propagation. They also clearly demonstrate that CSD
velocity is modulated dichotomously, namely, with deceleration
following synaptic serotonin increase (Amaˆncio-dos-Santos et al.,
2006) and acceleration following serotonin decrease (present results).
Serotonin seems to exert a mainly inhibitory role in the
activity of the central nervous system (Cooper et al., 1996; Vogt,
1982). For instance, serotoninergic system activation has been
considered a useful strategy for treating diseases like epilepsy,
migraine, and cerebral ischemia (Freitas et al., 2010; Lee et al.,
2011; Monteith and Goadsby, 2011; Mostert et al., 2008;
Trindade-Filho et al., 2008). The mechanisms underlying such
diseases have been associated with changes in brain excitability,
and seem to share some common features with those of CSD
(Le~ao, 1944; Read and Parsons, 2000). The present ﬁndings
additionally support this idea, and may contribute to the overall
understanding of the relationship between CSD and these neuro-
logical diseases.
Oxidative stress has been implicated in the mechanism of cell
death observed in seizures and cerebral ischemia (Betti et al.,
2011), and antioxidants reduce this effect (Pestana et al., 2010).
On the other hand, buspirone, a 5-HT1A receptor agonist, report-
edly exerts its anticonvulsant effects by inhibiting the develop-
ment of oxidative stress (Freitas et al., 2010). Moreover,
escitalopram, a selective serotonin reuptake inhibitor, seems to
play the same protective role against ischemia-induced neuronal
death (Lee et al., 2011). CSD has been considered as a sublethal
stressor (Lian and Stringer, 2004), and it has been shown that
antioxidants reduce the vulnerability of brain cells to oxidative
stress associated with CSD, either directly or by upregulating
genes involved in oxidative stress response (Choudhuri et al.,
2002). These data suggest the involvement of oxidative stress in
CSD, and raise the question of how the serotonin system may be
related.
It is possible that serotoninergic system stimulation could
inﬂuence CSD by reducing its stressful action. Despite being an
antidepressant, tianeptine decreases the serotonin availability in
the brain, which may attenuate the physiological mechanisms
that counteract the CSD-induced oxidative stress. This could
explain the increase in CSD propagation velocities observed in
the present work. In support of this hypothesis, tianeptine does
not prevent oxidative stress in an experimental model for fragile
X syndrome (Romero-Zerbo et al., 2009).
It is important to note that the effect of systemic tianeptine on
CSD was inﬂuenced by the nutritional status; well-nourished, but
not malnourished, animals treated with 10 mg/kg tianeptine
presented increased CSD propagation velocities compared with
the corresponding saline controls. Malnutrition reportedly modi-
ﬁes the action of some systemically injected substances on CSD
(Guedes et al., 1992), with injections of glucose or diazepam
modulating CSD velocity in well-nourished, but not in early-
malnourished, animals (Costa-Cruz and Guedes, 2001; Guedes
et al., 1992; Ximenes-da-Silva and Guedes, 1991). It has been
suggested that malnutrition promoted hypo-responsiveness to
those compounds. In another study, a reinforcement of the
pilocarpine effect was observed in malnourished animals com-
pared with the well-nourished controls (Vasconcelos et al., 2004).
Taken together, the data collectively suggest that, depending on
the involved neurotransmitter system, early malnutrition can
increase or decrease CSD responses to certain compounds com-
pared with the responses of the well-nourished brain. In the case
of systemic tianeptine, malnutrition seems to diminish the drugeffect on CSD. Both the neurophysiological (serotoninergic) and/or
pharmacodynamic and pharmacokinetic mechanisms of tianep-
tine could have contributed to the current observations on
malnutrition modulation. If this nutrition/CSD relationship can
be demonstrated in humans, it could improve predictions of the
effectiveness of distinct drugs therapeutically employed in the
neurological clinic, as the effectiveness may change as a function
of the early nutritional condition of the patient (Amaˆncio-dos-
Santos et al., 2006). Future experiments are required to test this
assumption.
It is worth noting that topical application of tianeptine was
more effective in accelerating CSD than systemic administration;
however, systemic tianeptine administration is more important
for use in humans than topical administration, since tianeptine is
regularly administered systemically. In the well-nourished ani-
mals, we found that topical tianeptine signiﬁcantly and dose-
dependently facilitated CSD propagation. The difference between
the systemic and topic CSD effects of tianeptine is not surprising,
since topical application may not be inﬂuenced by the body’s
metabolism, as occurs for systemic treatment (Royer et al., 1988).
It is well known that body metabolism can reduce drug activity
(Royer et al., 1988). Similar systemic versus topical differences
have been observed with other serotoninergic drugs (Amaˆncio-
dos-Santos et al., 2006; Guedes et al., 2002). The study of topical
application allows us to be more conﬁdent that the effects
encountered here were possibly due to the modiﬁcations in brain
serotonin availability, even though this amine concentration was
not measured in the present study. Furthermore, the topical
application experiments demonstrated that the CSD effects of
tianeptine were fully reversible, as documented in Figs. 4 and 5.
In conclusion, our novel data indicate that tianeptine exerts a
facilitating effect on CSD in the developing rat brain (as evidenced
by the systemic experiments), as well as in the adult brain (topic
application experiments). We also demonstrate that the effect of
systemic tianeptine on the developing brain is modulated by
nutritional status. Our results reinforce previous data that support
an antagonistic role for the serotoninergic system on CSD.Acknowledgments
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